Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Muscarinic control of cardiovascular function in humans: a review of current clinical evidence

Palma JA.

Clin Auton Res. 2024 Feb;34(1):31-44. doi: 10.1007/s10286-024-01016-5. Epub 2024 Feb 2.

The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer's Disease Risk

Asiamah EA, Feng B, Guo R, Yaxing X, Du X, Liu X, Zhang J, Cui H, Ma J.

J Alzheimers Dis. 2024;97(3):1007-1031. doi: 10.3233/JAD-230658.

Occupational Therapy Practice Guidelines for Adults Living With Alzheimer's Disease and Related Neurocognitive Disorders

Smallfield S, Metzger L, Green M, Henley L, Rhodus EK.

Am J Occup Ther. 2024 Jan 1;78(1):7801397010. doi: 10.5014/ajot.2024.078101.

A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease

Kourti M, Metaxas A.

Neurobiol Dis. 2024 Mar;192:106427. doi: 10.1016/j.nbd.2024.106427. Epub 2024 Feb 1.

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK.

Ageing Res Rev. 2024 Apr;96:102211. doi: 10.1016/j.arr.2024.102211. Epub 2024 Feb 1.

Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer's disease

Zhao R.

J Neuroinflammation. 2024 Feb 2;21(1):40. doi: 10.1186/s12974-024-03031-9.

Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?

Manoharan SD, Abdul Hamid H, Md Hashim NF, Cheema MS, Chiroma SM, Mustapha M, Mehat MZ.

Brain Res. 2024 Apr 15;1829:148793. doi: 10.1016/j.brainres.2024.148793. Epub 2024 Feb 1.

Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimer's disease

Chen XJ, Deng Z, Zhang LL, Pan Y, Fu J, Zou L, Bai Z, Xiao X, Sheng F.

Biomed Pharmacother. 2024 Mar;172:116222. doi: 10.1016/j.biopha.2024.116222. Epub 2024 Feb 3.

Harnessing Brain Pathology for Dementia Prevention

Leng Y, Yaffe K.

JAMA Neurol. 2024 Mar 1;81(3):229-231. doi: 10.1001/jamaneurol.2023.5490.

The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study

Akhgarjand C, Vahabi Z, Shab-Bidar S, Anoushirvani A, Djafarian K.

Inflammopharmacology. 2024 Apr;32(2):1413-1420. doi: 10.1007/s10787-023-01427-2. Epub 2024 Feb 6.

How donanemab data address the coverage with evidence development questions

Klein EG, Schroeder K, Wessels AM, Phipps A, Japha M, Schilling T, Zimmer JA.

Alzheimers Dement. 2024 Apr;20(4):3127-3140. doi: 10.1002/alz.13700. Epub 2024 Feb 7.

Memantine's double duty? Investigating its impact on epilepsy control in Alzheimer's disease

Rayala H, Kapur J, El-Haija HA, Parikh P, Zawar I.

Epileptic Disord. 2024 Apr;26(2):261-263. doi: 10.1002/epd2.20202. Epub 2024 Feb 9.

A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia

Crestini A, Carbone E, Rivabene R, Ancidoni A, Rosa P, Tata AM, Fabrizi E, Locuratolo N, Vanacore N, Lacorte E, Piscopo P.

Cells. 2024 Jan 26;13(3):237. doi: 10.3390/cells13030237.

From the Mind to the Spine: The Intersecting World of Alzheimer's and Osteoporosis

Margetts TJ, Wang HS, Karnik SJ, Plotkin LI, Movila A, Oblak AL, Fehrenbacher JC, Kacena MA.

Curr Osteoporos Rep. 2024 Feb;22(1):152-164. doi: 10.1007/s11914-023-00848-w. Epub 2024 Feb 9.

Artificial intelligence for drug discovery and development in Alzheimer's disease

Qiu Y, Cheng F.

Curr Opin Struct Biol. 2024 Apr;85:102776. doi: 10.1016/j.sbi.2024.102776. Epub 2024 Feb 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias